Cesar E Bogado
Overview
Explore the profile of Cesar E Bogado including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
437
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fitzpatrick L, Bilezikian J, Wooddell M, Paul G, Kolatkar N, Nino A, et al.
J Drug Assess
. 2016 Aug;
1(1):11-9.
PMID: 27536422
Objectives: Post-hoc analyses have shown an increase incidence of fractures among type 2 diabetes (T2DM) patients treated with thiazolidinediones (TZDs). The mechanisms by which TZDs may be associated with increased...
2.
Zebaze R, Libanati C, Austin M, Ghasem-Zadeh A, Hanley D, Zanchetta J, et al.
Bone
. 2013 Nov;
59:173-9.
PMID: 24275677
Vertebral fractures and trabecular bone loss are hallmarks of osteoporosis. However, 80% of fractures are non-vertebral and 70% of all bone loss is cortical and is produced by intracortical remodeling....
3.
Zanchetta M, Diehl M, Buttazzoni M, Galich A, Silveira F, Bogado C, et al.
J Bone Miner Res
. 2013 Oct;
29(4):999-1004.
PMID: 24115250
Reports of atypical femoral fractures (AFFs) in patients receiving long- term bisphosphonate therapy have raised concerns regarding the genesis of this rare event. Using high-resolution peripheral quantitative computed tomography (HR-pQCT),...
4.
Burghardt A, Pialat J, Kazakia G, Boutroy S, Engelke K, Patsch J, et al.
J Bone Miner Res
. 2012 Oct;
28(3):524-36.
PMID: 23074145
High-resolution peripheral quantitative computed tomography (HR-pQCT) has recently been introduced as a clinical research tool for in vivo assessment of bone quality. The utility of this technology to address important...
5.
Bogado C, Boailchuk J, Zanchetta M, Massari F, Zanchetta J
Drugs Today (Barc)
. 2011 Aug;
47(8):605-13.
PMID: 21850283
Denosumab is a fully human monoclonal antibody that inhibits the formation, function and survival of osteoclasts, preventing the interaction of tumor necrosis factor ligand superfamily member 11 (receptor activator of...
6.
Bogado C, Zanchetta M, Boailchuk J, Massari F, Zanchetta J
Curr Osteoporos Rep
. 2010 Dec;
9(1):12-9.
PMID: 21132405
Denosumab is the first fully human monoclonal antibody that inhibits the formation, function, and survival of osteoclasts by blocking the interaction of receptor activator of nuclear factor-κB (RANK) ligand with...
7.
Zanchetta J, Bogado C, Cisari C, Aslanidis S, Greisen H, Fox J, et al.
Curr Med Res Opin
. 2010 Oct;
26(11):2627-33.
PMID: 20923256
Objective: To determine the safety and efficacy of full-length parathyroid hormone, PTH(1-84), treatment for up to 36 months by evaluating bone mineral density (BMD) changes, bone histomorphometric indices, and clinical...
8.
Bogado C, Massari F, Zanchetta J
Womens Health (Lond)
. 2009 Oct;
2(3):447-57.
PMID: 19803916
Osteoporosis-related fractures are a major public health problem worldwide. Antiresorptive drugs, which work principally by suppressing bone resorption, are the established therapeutic approach for the prevention of fragility fractures in...
9.
Roldan E, Bogado C
Curr Osteoporos Rep
. 2009 Jul;
7(2):37-41.
PMID: 19631026
Peripheral quantitative computed tomography (pQCT) systems measure bone parameters noninvasively using low radiation doses. This limits image resolution but is practical for the diagnosis and quantitative monitoring of the properties...
10.
Engelke K, Adams J, Armbrecht G, Augat P, Bogado C, Bouxsein M, et al.
J Clin Densitom
. 2008 Apr;
11(1):123-62.
PMID: 18442757
The International Society for Clinical Densitometry (ISCD) has developed Official Positions for the clinical use of dual-energy X-ray absorptiometry (DXA) and non-DXA technologies. While only DXA can be used for...